Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 133 member G, pseudogene (FAM133GP) is a non-coding genomic locus found on chromosome 12p12.1. It is classified as a pseudogene, meaning it is a sequence that resembles a functional gene but does not encode a protein due to accumulated disabling mutations. While some pseudogenes can have regulatory roles in gene expression or be transcribed as non-coding RNAs, there is currently no evidence that FAM133GP is functional or implicated in any disease process. It is not considered a therapeutic target, biomarker, or safety risk. Like other pseudogenes, it is of potential genomic interest for evolutionary studies and may, theoretically, be investigated for non-coding RNA regulatory functions, but currently there is no supporting data for such roles in FAM133GP[1][3][5]. Key points: - FAM133GP is a pseudogene and not a therapeutic target - No evidence of protein expression, disease relevance, or drug interaction - No safety, biomarker, or mechanism of action attributes - May be of interest only in the broader study of non-coding RNA biology or genome evolution
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 133 member G, pseudogene (FAM133GP).